Cargando…

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease

Apolipoprotein A-I (apoA-I) and high-density lipoproteins (HDL) mediate reverse cholesterol transport out of cells. Furthermore, HDL has additional protective functions, which include anti-oxidative, anti-inflammatory, anti-apoptotic, and vasoprotective effects. In contrast, HDL can become dysfuncti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Elizabeth M., Figueroa, Debbie M., Barochia, Amisha V., Yao, Xianglan, Levine, Stewart J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030281/ https://www.ncbi.nlm.nih.gov/pubmed/27708582 http://dx.doi.org/10.3389/fphar.2016.00323

Ejemplares similares

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Apolipoproteins: New players in cancers
por: He, Yingcheng, et al.
Publicado: (2022)

Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
por: Nguyen, David, et al.
Publicado: (2013)

Apolipoprotein A-I and Cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2015)

Monocyte to high-density lipoprotein and apolipoprotein A1 ratios are associated with bone homeostasis imbalance caused by chronic inflammation in postmenopausal women with type 2 diabetes mellitus
por: Huang, Rong, et al.
Publicado: (2022)

Importance of Apolipoprotein A-I in Multiple Sclerosis
por: Gardner, Lidia A., et al.
Publicado: (2015)

The Role of High-Density Lipoprotein in COVID-19
por: Wang, Guyi, et al.
Publicado: (2021)

Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma
por: Huang, Rong, et al.
Publicado: (2011)

Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins in vitro
por: Yan, Ying, et al.
Publicado: (2019)

Development of activated endothelial targeted high-density lipoprotein nanoparticles
por: Yu, Minzhi, et al.
Publicado: (2022)

Relationship between non–high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
por: Li, Ya, et al.
Publicado: (2020)

Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia
por: Gibbons, Andrew Stuart, et al.
Publicado: (2010)

Structural Insights into High Density Lipoprotein: Old Models and New Facts
por: Gogonea, Valentin
Publicado: (2016)

Regulation of adipocyte autophagy — The potential anti-obesity mechanism of high density lipoprotein and ApolipoproteinA-I
por: Wang, Shuai, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023)

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010)

Serum levels of apolipoprotein A-I and high-density lipoprotein can predict organ failure in acute pancreatitis
por: Peng, Yun-Shing, et al.
Publicado: (2015)

Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion
por: Fisher, Eric, et al.
Publicado: (2014)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution
por: Tian, Li, et al.
Publicado: (2011)

The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice
por: Lagor, William R., et al.
Publicado: (2012)

The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout
por: Rasheed, Humaira, et al.
Publicado: (2014)

Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice
por: Ardaiz, Nuria, et al.
Publicado: (2021)

Association of the Apolipoprotein B/Apolipoprotein A-I Ratio, Metabolic Syndrome Components, Total Cholesterol, and Low-Density Lipoprotein Cholesterol with Insulin Resistance in the Population of Georgia
por: Makaridze, Zaza, et al.
Publicado: (2014)

The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis
por: Hansen, John-Bjarne, et al.
Publicado: (2011)

The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy
por: Oda, Michael N, et al.
Publicado: (2013)

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
por: Faguer, Stanislas, et al.
Publicado: (2022)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a)
por: Dati, Francesco, et al.
Publicado: (2001)

Apolipoprotein M promotes the anti-inflammatory effect of high-density lipoprotein by binding to scavenger receptor BI
por: Yao, Shuang, et al.
Publicado: (2020)

Low-Density Lipoprotein Receptor Deficiency Attenuates Neuroinflammation through the Induction of Apolipoprotein E
por: Mailleux, Jo, et al.
Publicado: (2017)

Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins
por: Zannis, Vassilis I., et al.
Publicado: (2017)

Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2017)

Apolipoprotein A1 and Low-Density Lipoprotein as Risk Factors for Intraocular Metastases in Postmenopausal Breast Cancer
por: Li, Biao, et al.
Publicado: (2021)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019)

Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
por: Duan, Huxinyue, et al.
Publicado: (2023)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

A CCL24-dependent Pathway Augments Eosinophilic Airway Inflammation in House Dust Mite-challenged Cd163(−/−) Mice
por: Dai, Cuilian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m5716npe3ku2shmdssctcsl3jd